- This event has passed.
Rare Disease Symposium
March 1, 2017 @ 8:30 am - 2:30 pm
The UNC Catalyst for Rare Diseases hosted a Rare Disease Symposium on Wednesday, March 1, 2017, at The Carolina Club, Chapel Hill, NC. The Symposium brought together board members and strategic partners to discuss the needs and direction for rare disease research and for UNC Catalyst.
The presenters’ slides are available for download at the links below.
Robert A. “Bob” Blouin, PharmD
Dean, UNC Eshelman School of Pharmacy
|9:15AM||“Open Science Accelerating Drug Discovery”
Wenhwa Lee, MSc, PhD
Director, Disease Foundations Network SGC Oxford
|9:45AM||“Identifying, Characterizing, and Modulating Regulatory Elements in Their Natural Context”
Greg Crawford, PhD – Associate Professor, Pediatrics/Duke Center for Genomic and Computational Biology
|10:30AM||“Constructing an Atlas of the Human Metabolome to Enable Phenotyping, Genome Mapping and Understanding Genetic Disease”
Mike Milburn, PhD, CSO, Metabolon
|11:00AM||“Gene Awakenings for the Treatment of Angelman Syndrome”
Ben Philpot, PhD, Professor and Associate Director, UNC Neuroscience Center
|11:30AM||“Initiation of First-in-Human Gene Therapy for Rare Neurological Diseases”
Steven J. Gray, PhD, Asst. Professor
Dept. of Ophthalmology, UNC Gene Therapy Center
|12:45PM||“Creating an Uber Model for Rare Disease Drug Discovery: Putting People in the Driver’s Seat”
Sharon Terry, MA, President and CEO, Genetic Alliance
|1:15PM||“Industrializing Rare Disease Therapy Discovery and Development”
Sean Ekins, PhD, DSc, CEO and Founder, Collaborations Pharmaceuticals
|1:45PM – 2:30PM||PANEL DISCUSSION